Disparities in Hormone Replacement Therapy Prescribing for Women with Intellectual Disabilities
Saved in:
| Title: | Disparities in Hormone Replacement Therapy Prescribing for Women with Intellectual Disabilities |
|---|---|
| Language: | English |
| Authors: | Charis Bontoft (ORCID |
| Source: | Journal of Applied Research in Intellectual Disabilities. 2026 39(2). |
| Availability: | Wiley. Available from: John Wiley & Sons, Inc. 111 River Street, Hoboken, NJ 07030. Tel: 800-835-6770; e-mail: cs-journals@wiley.com; Web site: https://www.wiley.com/en-us |
| Peer Reviewed: | Y |
| Page Count: | 10 |
| Publication Date: | 2026 |
| Document Type: | Journal Articles Reports - Research |
| Descriptors: | Intellectual Disability, Females, Drug Therapy, Physiology, Foreign Countries, Adults, Health Services |
| Geographic Terms: | United Kingdom |
| DOI: | 10.1111/jar.70192 |
| ISSN: | 1360-2322 1468-3148 |
| Abstract: | Background: People with intellectual disabilities who menstruate are underrepresented in menopause research and care. Methods: A mixed-methods service evaluation was conducted in one NHS Trust. In Phase 1, prescribing data from electronic health records for women aged 40-79 with intellectual disabilities (n = 149) was extracted and statistically compared to estimates for the general population. Phase 2 comprised a focus group with psychiatrists (n = 6) and an interview with a GP (n = 1); data were analysed using framework analysis. Findings: HRT was prescribed to 3.3% of people with intellectual disabilities, versus 17.2% in the general population, indicating significantly lower prescribing (p < 0.0001). Qualitative themes highlighted low clinician awareness, diagnostic overshadowing, concerns about monitoring and system-level issues. Facilitators included psychiatrist advocacy, proactive carers and clearer primary-to-secondary care collaboration. Conclusions: Women with LD were substantially less likely to receive HRT, suggesting a marked inequity in menopause care. Recommendations are made to improve recognition, treatment access and outcomes. |
| Abstractor: | As Provided |
| Entry Date: | 2026 |
| Accession Number: | EJ1504027 |
| Database: | ERIC |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: eric DbLabel: ERIC An: EJ1504027 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Disparities in Hormone Replacement Therapy Prescribing for Women with Intellectual Disabilities – Name: Language Label: Language Group: Lang Data: English – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Charis+Bontoft%22">Charis Bontoft</searchLink> (ORCID <externalLink term="https://orcid.org/0000-0001-9577-6773">0000-0001-9577-6773</externalLink>)<br /><searchLink fieldCode="AR" term="%22Indermeet+Sawhney%22">Indermeet Sawhney</searchLink> (ORCID <externalLink term="https://orcid.org/0000-0001-6554-5472">0000-0001-6554-5472</externalLink>)<br /><searchLink fieldCode="AR" term="%22Asif+Zia%22">Asif Zia</searchLink><br /><searchLink fieldCode="AR" term="%22Danielle+Adams%22">Danielle Adams</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="SO" term="%22Journal+of+Applied+Research+in+Intellectual+Disabilities%22"><i>Journal of Applied Research in Intellectual Disabilities</i></searchLink>. 2026 39(2). – Name: Avail Label: Availability Group: Avail Data: Wiley. Available from: John Wiley & Sons, Inc. 111 River Street, Hoboken, NJ 07030. Tel: 800-835-6770; e-mail: cs-journals@wiley.com; Web site: https://www.wiley.com/en-us – Name: PeerReviewed Label: Peer Reviewed Group: SrcInfo Data: Y – Name: Pages Label: Page Count Group: Src Data: 10 – Name: DatePubCY Label: Publication Date Group: Date Data: 2026 – Name: TypeDocument Label: Document Type Group: TypDoc Data: Journal Articles<br />Reports - Research – Name: Subject Label: Descriptors Group: Su Data: <searchLink fieldCode="DE" term="%22Intellectual+Disability%22">Intellectual Disability</searchLink><br /><searchLink fieldCode="DE" term="%22Females%22">Females</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Therapy%22">Drug Therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Physiology%22">Physiology</searchLink><br /><searchLink fieldCode="DE" term="%22Foreign+Countries%22">Foreign Countries</searchLink><br /><searchLink fieldCode="DE" term="%22Adults%22">Adults</searchLink><br /><searchLink fieldCode="DE" term="%22Health+Services%22">Health Services</searchLink> – Name: Subject Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22United+Kingdom%22">United Kingdom</searchLink> – Name: DOI Label: DOI Group: ID Data: 10.1111/jar.70192 – Name: ISSN Label: ISSN Group: ISSN Data: 1360-2322<br />1468-3148 – Name: Abstract Label: Abstract Group: Ab Data: Background: People with intellectual disabilities who menstruate are underrepresented in menopause research and care. Methods: A mixed-methods service evaluation was conducted in one NHS Trust. In Phase 1, prescribing data from electronic health records for women aged 40-79 with intellectual disabilities (n = 149) was extracted and statistically compared to estimates for the general population. Phase 2 comprised a focus group with psychiatrists (n = 6) and an interview with a GP (n = 1); data were analysed using framework analysis. Findings: HRT was prescribed to 3.3% of people with intellectual disabilities, versus 17.2% in the general population, indicating significantly lower prescribing (p < 0.0001). Qualitative themes highlighted low clinician awareness, diagnostic overshadowing, concerns about monitoring and system-level issues. Facilitators included psychiatrist advocacy, proactive carers and clearer primary-to-secondary care collaboration. Conclusions: Women with LD were substantially less likely to receive HRT, suggesting a marked inequity in menopause care. Recommendations are made to improve recognition, treatment access and outcomes. – Name: AbstractInfo Label: Abstractor Group: Ab Data: As Provided – Name: DateEntry Label: Entry Date Group: Date Data: 2026 – Name: AN Label: Accession Number Group: ID Data: EJ1504027 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=eric&AN=EJ1504027 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/jar.70192 Languages: – Text: English PhysicalDescription: Pagination: PageCount: 10 Subjects: – SubjectFull: Intellectual Disability Type: general – SubjectFull: Females Type: general – SubjectFull: Drug Therapy Type: general – SubjectFull: Physiology Type: general – SubjectFull: Foreign Countries Type: general – SubjectFull: Adults Type: general – SubjectFull: Health Services Type: general – SubjectFull: United Kingdom Type: general Titles: – TitleFull: Disparities in Hormone Replacement Therapy Prescribing for Women with Intellectual Disabilities Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Charis Bontoft – PersonEntity: Name: NameFull: Indermeet Sawhney – PersonEntity: Name: NameFull: Asif Zia – PersonEntity: Name: NameFull: Danielle Adams IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1360-2322 – Type: issn-electronic Value: 1468-3148 Numbering: – Type: volume Value: 39 – Type: issue Value: 2 Titles: – TitleFull: Journal of Applied Research in Intellectual Disabilities Type: main |
| ResultId | 1 |